VistaGen Therapeutics (VTGN) USPTO patents

Utility

Synthesis of 4-CHLOROKYNURENINES and Intermediates

9 Sep 21

The invention relates to an overall enantio-specific synthesis of 4-chlorokynurenine compounds, in particular L-4-chlorokynurenine, with improved yields.

Daniel LEVIN, Peter LEEMING, Emerich EISENREICH, Xuejun Karl LIU

Filed: 11 Feb 19

Utility

Dosage forms and therapeutic uses of L-4-chlorokynurenine

2 Nov 20

Compositions of L-4-chlorokynurenic are provided, as are methods for the treatment of neurological dysfunction.

H. Ralph Snodgrass, Allen E. Cato, Jack S. Hicklin

Filed: 7 Jun 18

Utility

Dosage forms and therapeutic uses of L-4-chlorokynurenine

27 Apr 20

Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurologica dyslinction.

H. Ralph Snodgrass, Allen E. Cato, Jack S. Hicklin

Filed: 13 May 18

Utility

Dosage forms and therapeutic uses of L-4-chlorokynurenine

13 Apr 20

Compositions of L-4-chlorokynurenine are provided, as are methods for the treatment of neurological dysfunction.

H. Ralph Snodgrass, Allen E. Cato, Jack S. Hicklin

Filed: 7 Jun 18

Utility

Therapeutic Uses of L-4-CHLOROKYNURENINE

23 Oct 19

Pharmaceutical compositions comprising L-4-chlorokynurenine and associated therapeutic methods are provided for the treatment of certain neurological and other conditions.

H. Ralph SNODGRASS

Filed: 5 May 19